Spotlight: Early Response to Ketamine for Suicidal Crisis Reduces Suicidal Events at 3 Months (Pastre, et al, 2025)
"This is the first study demonstrating that early SI response to IV ketamine is associated with a reduced risk of suicidal events at 3 months. These findings support ketamine's unique antisuicidal properties beyond its antidepressant effects, highlighting its potential role in suicide prevention."
Early Response to Ketamine for Suicidal Crisis Reduces Suicidal Events at 3 Months - PubMed
<span><b>Background:</b> Intravenous (IV) ketamine has demonstrated rapid reduction of suicidal ideation (SI), but its impact on suicidal attempts remains unclear. This study investigates the effect of IV ketamine on SI at 7 days and suicidal events (suicide attempt or hospitalizations for SI) at 3 months</span> …
Martin Pastre
Respuesta temprana a la ketamina por crisis suicida reduce eventos suicidas a los 3 meses (Pastre, et al, 2025)
Este es el primer estudio que demuestra que la respuesta temprana de SI a la ketamina intravenosa se asocia con un riesgo reducido de eventos suicidas a los 3 meses. Estos hallazgos apoyan las propiedades antissuicidas únicas de la ketamina más allá de sus efectos antidepresivos, destacando su papel potencial en la prevención del suicidio.
